More health systems across the U.S. are offering monoclonal antibody treatment as a way of fighting COVID-19 infection, but how exactly do the treatments work, and how effective are they in reducing ...

The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...